Clinical Trials on SARS Cov2, Immune Response in Singapore
Total 9 results
-
Arcturus Therapeutics, Inc.Terminated
-
Arcturus Therapeutics, Inc.Completed
-
Singapore General HospitalCompletedCOVID | ARDS, Human | Sars-CoV2Singapore
-
Becton, Dickinson and CompanyWithdrawn
-
Arcturus Therapeutics, Inc.RecruitingCOVID-19 | Corona Virus Infection | SARS-CoV-2 InfectionUnited States, Singapore
-
Tan Tock Seng HospitalNational Healthcare Group, Singapore; Singapore Immunology NetworkUnknownDiabetes Mellitus | Immune Response | Vitamin D Deficiency | Elderly | Influenza Vaccine | Metabolic DiseaseSingapore
-
Arcturus Therapeutics, Inc.TerminatedCovid19 | Corona Virus Infection | SARS-CoV InfectionUnited States, Singapore
-
Al-Azhar UniversityHelwan University; National Liver Institute, EgyptCompletedCOVID-19 | Cholangiocarcinoma | SARS-CoV-2 | Pancreas Cancer | Obstructive Jaundice | Cholangitis, Secondary BiliarySingapore, Germany, United States, Egypt, Peru
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2United States, Belgium, Canada, France, Spain, Denmark, Thailand, Vietnam, Korea, Republic of, United Kingdom, Malaysia, Israel, Taiwan, Australia, Germany, Poland, Singapore, United Arab Emirates